Expertise: Child Survival, HIV/AIDS, Malaria, Global Poverty, Global Partner Alliance, Wydick Research
Scott leads Compassion’s global advocacy efforts that raise the awareness of the global Church to the needs of children in poverty and seek to mobilize the Church to serve them. Prior to his current role, he served as senior vice president of international partner development, the primary liaison between Compassion International and its Global Partner Alliance countries. During his tenure at Compassion, he has also served as senior ministry advisor to the president’s office, international health specialist and as director of the organization’s AIDS initiative, Child Survival Program and Complementary Interventions program.
Scott is on the board of directors for North America’s largest network of Christian relief and development organizations (ACCORD). He has authored several works, including Hope Rising: How Christians Can End Extreme Poverty in this Generation. He is co-author of Shared Strength: Exploring Cross-Cultural Christian Partnerships and Relentless Hope: The Unstoppable Movement of Disciple-Making Communities. Scott was also one of the architects and chair of Live58, an action-based alliance of world-class, poverty-fighting organizations with a goal of ending extreme poverty.
"In the past 20 years, extreme poverty has been cut in half. That’s in just one generation," says Scott. "Progress is being made across the globe – from the decline in childhood disease death rates to curbing the spread of HIV. The numbers are astounding. Yes, the needs are still great, but the tyranny of extreme poverty is being broken."
A passionate follower of Jesus Christ, Scott left academic research to join Compassion in 2003. Previously, he was an award-winning scientist and recipient of multiple medical research grants. After receiving his doctorate in immunology from the University of California, he was a National Lymphoma Foundation Scholar at Stanford Medical Center and a professor of molecular, cell and developmental biology at Kansas State University. Scott holds a patent for the treatment of Hepatitis C.
His personal experiences with the poor greatly influenced this career decision, including one such encounter with an HIV-infected child named Jacqueline. Scott fought to save her life using anti-retroviral drugs, but she was too weak and her condition too advanced. Jacqueline died, and Scott vowed to honor her memory: "I told myself I’d do whatever it takes, with whatever influence God grants, to not be too late for the rest of the children."
Scott is a sought-after and gifted communicator with a passion for making the case that ending extreme poverty is not just possible, but probable in our lifetime.
"God has given me countless experiences with the poor. They has all woven into my life and helped shape who I am. I hope to continue to be a servant of God by ministering to the poor, to 'lose the chains of injustice and untie the cords of the yoke, to set the oppressed free, to share food with the hungry and provide the poor wanderer with shelter, to clothe the naked and not turn away from our own flesh and blood.'" (Adapted from Isaiah 58: 6-7)
Scott enjoys biking, hiking, playing golf and spending time with his family.
- 1996-98, Postdoctoral Fellow – Oncology, Stanford Medical Center, Division of Oncology
- 1991-96, Ph.D., Immunology, University of California, San Diego
- 1987-91, B.S., Microbiology, Cum Laude, Kansas State University
- National Institutes of Health, Grant Winner, 2001-04
- American Cancer Society Grant Winner, 2003
- Presidential Award for Excellence in Undergraduate Education, 2002
- National Science Foundation – First Award Winner, 2000
- Lymphoma Research Foundation Scholar, 1997-98
- National Institute of Health Postdoctoral Fellowship (National Cancer Institute) – Stanford University, 1997-98
- Achievement Rewards for College Scientists scholar
- State of Kansas scholar
English and Greek
'Inhibition of Hepatitis C Virus Envelop Protein E2 Binding to its Cellular Receptor, CD81, by Imidazole-4, 5—Docarboxamide Derivatives'
Co-inventors: Paul W. Baures and Scott C. Todd